日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma

动态BH3谱分析可识别用于治疗恶性胸膜间皮瘤的促凋亡药物组合

Danielle S Potter ,Ruochen Du ,Stephan R Bohl ,Kin-Hoe Chow ,Keith L Ligon ,Raphael Bueno ,Anthony Letai

Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma

蛋白质组学分析显示 CDK6 上调是多发性骨髓瘤中来那度胺的可靶向耐药机制

Yuen Lam Dora Ng #, Evelyn Ramberger #, Stephan R Bohl, Anna Dolnik, Christian Steinebach, Theresia Conrad, Sina Müller, Oliver Popp, Miriam Kull, Mohamed Haji, Michael Gütschow, Hartmut Döhner, Wolfgang Walther, Ulrich Keller, Lars Bullinger, Philipp Mertins, Jan Krönke

Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myeloma

全面的 CRISPR-Cas9 筛查可确定多发性骨髓瘤药物反应的遗传决定因素

Stephan R Bohl, Laura K Schmalbrock, Imke Bauhuf, Tatjana Meyer, Anna Dolnik, Martin Szyska, Tamara J Blätte, Sarah Knödler, Linda Röhner, Denise Miller, Miriam Kull, Christian Langer, Hartmut Döhner, Anthony Letai, Frederik Damm, Dirk Heckl, Lars Bullinger, Jan Krönke

Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia

线粒体凋亡启动减少导致急性髓系白血病对BH3模拟物产生耐药性

Shruti Bhatt ,Marissa S Pioso ,Elyse Anne Olesinski ,Binyam Yilma ,Jeremy A Ryan ,Thelma Mashaka ,Buon Leutz ,Sophia Adamia ,Haoling Zhu ,Yanan Kuang ,Abhishek Mogili ,Abner Louissaint Jr ,Stephan R Bohl ,Annette S Kim ,Anita K Mehta ,Sneha Sanghavi ,Youzhen Wang ,Erick Morris ,Ensar Halilovic ,Cloud P Paweletz ,David M Weinstock ,Jacqueline S Garcia ,Anthony Letai